Progress in Neuro-Psychopharmacology & Biological Psychiatry

Papers
(The H4-Index of Progress in Neuro-Psychopharmacology & Biological Psychiatry is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Younger people are more vulnerable to stress, anxiety and depression during COVID-19 pandemic: A global cross-sectional survey374
COVID-19 pandemic impact on children and adolescents' mental health: Biological, environmental, and social factors342
Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies222
The prevalence of anxiety and depression among healthcare workers during the COVID-19 pandemic: An umbrella review of meta-analyses164
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?141
New mechanism of neuroinflammation in Alzheimer's disease: The activation of NLRP3 inflammasome mediated by gut microbiota113
Psychiatric symptomatology associated with depression, anxiety, distress, and insomnia in health professionals working in patients affected by COVID-19: A systematic review with meta-analysis109
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease108
Psychological effects caused by the COVID-19 pandemic in health professionals: A systematic review with meta-analysis104
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review93
Mental health consequences of the Covid-19 outbreak in Spain. A longitudinal study of the alarm situation and return to the new normality91
Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysis90
The impact of COVID-19 lockdown on social network sites use, body image disturbances and self-esteem among adolescent and young women88
Prevalence of anxiety in health care professionals during the COVID-19 pandemic: A rapid systematic review (on published articles in Medline) with meta-analysis87
The SARS-CoV-2 and mental health: From biological mechanisms to social consequences86
Consequences of the COVID-19 pandemic on admissions to general hospital psychiatric wards in Italy: Reduced psychiatric hospitalizations and increased suicidality61
Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence60
Gambling and the COVID-19 pandemic: A scoping review59
Anomalous intrinsic connectivity within and between visual and auditory networks in major depressive disorder57
Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis52
Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation52
Anorexia nervosa and gut microbiota: A systematic review and quantitative synthesis of pooled microbiological data47
Graph theory approach for the structural-functional brain connectome of depression46
Depression: Biological markers and treatment45
Post-infection depressive, anxiety and post-traumatic stress symptoms: A prospective cohort study in patients with mild COVID-1945
The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present45
Gut microbiota-derived vitamins – underrated powers of a multipotent ally in psychiatric health and disease44
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach44
Role of interleukin 8 in depression and other psychiatric disorders44
Dysregulation in IL-6 receptors is associated with upregulated IL-17A related signaling in CD4+ T cells of children with autism43
Gut-brain axis: A matter of concern in neuropsychiatric disorders…!41
Psychologic distress and sleep quality among adults in Turkey during the COVID-19 pandemic41
BDNF and pro-BDNF in serum and exosomes in major depression: Evolution after antidepressant treatment41
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression40
Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder40
Brain-derived neurotrophic factor (BDNF) and inflammatory markers: Perspectives for the management of depression40
Rumination network dysfunction in major depression: A brain connectome study40
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects38
Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis38
Efficacy and tolerability of theta-burst stimulation for major depression: A systematic review and meta-analysis38
Philosophy for children and mindfulness during COVID-19: Results from a randomized cluster trial and impact on mental health in elementary school students38
0.031527042388916